|Articles|April 1, 2004

April 2004
Volume 10
Issue 4

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

Author(s)Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD, Brenda Motheral, PhD, Doug Mager, BS

Articles in this issue

almost 22 years ago

Article

Improving Cancer Screening Adherence: Using the "Teachable Moment" as a Delivery Setting for Educational Interventions

almost 22 years ago

Article

Population-Based Hepatitis C Surveillance and Treatment in a National Managed Care Organization

almost 22 years ago

Article

Malpractice Prevention, Patient Safety, and Quality of Care: A Critical Linkage

almost 22 years ago

Article

Comparing Breast Cancer Case Identification Using HMO Computerized Diagnostic Data and SEER Data

almost 22 years ago

Article

Health Plan Policies and Programs for Colorectal Cancer Screening: A National Profile

almost 22 years ago

Article

Primary Care Practice and Facility Quality Orientation: Influence on Breast and Cervical Cancer Screening Rates

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

How Do GLP-1 Agonists Fit Into Stroke Care?

Exploring Identity, Appearance Experiences Among Patients With Alopecia